Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns Trump says he will spend up to $500 million of 'my money' to help Republicans in midterms How to secure edge AI in customer-owned environments | Microsoft Security Blog British army told to stop non-essential training exercises to save money Hugging Face goes from a ‘scrappy’ startup named after an emoji to $13 billion Nvidia acquisition

Matthew Rabinowitz

Matthew Rabinowitz

Matthew Rabinowitz (#2226)

Global Rank #2226
Country Rank #751
Country United States

Matthew Rabinowitz is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 2 B
  • Health diagnostics
  • United States
  • M
  • 53 Years

Snapshot

Quick Facts

Global Rank #2,226
Country Rank #751
Net Worth $1.9B
Previous Worth $1.8B
Worth Change +$0.1B
Country United States
Industry Health diagnostics
Age 53 Years
Gender M
Last Refreshed 09 Sep 2026, 12:00 AM
Residence Miami, Florida
Citizenship United States
World Billionaires List United States Billionaires Health diagnostics

Profile Data

Personal Stats

Age 53
Source Of Wealth Health diagnostics, Self Made
Residence Miami, Florida
Citizenship United States
Education Ph.D, Stanford University; Master of Science, Stanford University; Bachelor of Arts, Stanford University
Net Worth Change +$0.1B +5.6% from previous worth
Previous Net Worth $1.8B
Current Net Worth $1.9B

About Me

Matthew Rabinowitz is the cofounder and executive chairman of clinical genetic testing and molecular diagnostics firm Natera. He cofounded the Austin, Texas-based company in 2004 after his nephew died from a severe genetic condition six days after birth. Rabinowitz and his cofounder Jonathan Sheena took the company public on the Nasdaq in 2015; he owns about 2% of the company's shares plus several options tranches. In 2017, he cofounded clinical whole genome analysis platform company MyOme. The firm was valued at $187 million in December 2025 and Rabinowitz owns a 19% stake. Born in South Africa to parents who were both doctors, Rabinowitz came to the U.S. in 1992 to attend Stanford University.

Wealth Growth

Net Worth Growth Over Time

Tracking Matthew Rabinowitz's net worth journey over the years, highlighting key growth phases and financial milestones.

© Iconic Billionaires